Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-03-05
1978-08-15
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424263, A01N 920, A01N 922
Patent
active
041073312
ABSTRACT:
Fungi requiring zinc ions are killed by applying to the fungi compounds capable of chelating zinc in concentrations of at least 3.5%. The invention is particularly effective in treating candida albicans.
REFERENCES:
patent: 2836537 (1958-05-01), Skaptason
patent: 2875129 (1959-02-01), Bersworth et al.
patent: 3052604 (1962-09-01), Davis et al.
patent: 3184381 (1965-05-01), Ashmead et al.
patent: 3240701 (1966-03-01), Furia
patent: 3514481 (1970-05-01), Gordon
patent: 3935862 (1976-02-01), Kraskin
patent: 3950536 (1976-04-01), Barer et al.
Weinberg, "Infectious Diseases Influenced by Trace Element Environment", Annal. of the New York Academy of Sciences, vol. 199, pp. 274-282. 6/72.
Goodman et al., The Pharmacological Basis of Therapeutics, 3rd Ed., pp. 934-935.
Halsted et al., The Lancet, 2/70, pp. 322-324.
LandOfFree
Zinc chelating fungicidal composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zinc chelating fungicidal composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zinc chelating fungicidal composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1435491